Filtros de búsqueda

Lista de obras de

A Pathological Study Using 2014 WHO Criteria Reveals Poor Prognosis of Grade 3 Ovarian Endometrioid Carcinomas.

artículo científico publicado en 2018

A case of refeeding syndrome in pregnancy with anorexia nervosa

artículo científico publicado en 2017

A case of spontaneous ovarian hyperstimulation syndrome after vaginal delivery

scientific article published on 19 June 2019

A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: Prognosis according to the new 2018 staging system, comparing outcomes for different chemotherapeutic regimens and histopathological subtypes

artículo científico publicado en 2019

A non-randomized confirmatory study regarding selection of fertility-sparing surgery for patients with epithelial ovarian cancer: Japan Clinical Oncology Group Study (JCOG1203).

artículo científico publicado en 2015

A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study)

scientific article published on 24 May 2019

A rare case of Coombs-negative autoimmune haemolytic anaemia in pregnancy

artículo científico publicado en 2018

ACTN4 gene amplification and actinin-4 protein overexpression drive tumour development and histological progression in a high-grade subset of ovarian clear-cell adenocarcinomas

artículo científico publicado en 2012

Aberrant Expression of the Mammalian Target of Rapamycin, Hypoxia-inducible Factor-1α, and Glucose Transporter 1 in the Development of Ovarian Clear-cell Adenocarcinoma ⬇️

artículo científico publicado el 1 de mayo de 2012

Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways

artículo científico publicado en 2009

Accumulative copy number increase of MET drives tumor development and histological progression in a subset of ovarian clear-cell adenocarcinomas ⬇️

artículo científico publicado el 7 de octubre de 2011

Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: a retrospective analysis.

artículo científico publicado en 2018

Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour

artículo científico publicado en 2015

Amplification of GNAS may be an independent, qualitative, and reproducible biomarker to predict progression-free survival in epithelial ovarian cancer

artículo científico publicado en 2010

An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway

artículo científico publicado en 2009

An extremely rare case of adenoma malignum with large cystic tumor which resulted in urinary obstruction

artículo científico publicado en 2002

Analysis of prophylactic Bakri balloon tamponade failure in patients with placenta previa

scientific article published on 01 January 2019

Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).

artículo científico publicado en 2016

Aquaporin 3 Expression in Endometrioid Carcinoma of the Uterine Body Correlated With Early Stage and Lower Grade

scientific article published on 08 May 2020

Cervical varicosities may predict placenta accreta in posterior placenta previa: a magnetic resonance imaging study.

artículo científico publicado en 2017

Clear cell adenocarcinoma with a component of poorly differentiated histology: a poor prognostic subgroup of ovarian clear cell adenocarcinoma

artículo científico publicado en 2011

Clear cell carcinoma of the ovary: Is there a role of histology-specific treatment? ⬇️

artículo científico publicado el 1 de junio de 2012

Clear cell histology as a poor prognostic factor for advanced epithelial ovarian cancer: a single institutional case series through central pathologic review ⬇️

artículo científico publicado el 8 de enero de 2013

Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A).

artículo científico

Co-Expression of Mesothelin and CA125 Is Associated with the Poor Prognosis of Endometrial Serous Carcinoma and Mixed Carcinomas Including Serous Carcinoma

artículo científico publicado en 2020

Combination of irinotecan and platinum for platinum-resistant or refractory recurrent ovarian cancers: A preliminary case series

artículo científico publicado en 2017

Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial

scientific article published on 13 March 2020

Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncol

artículo científico publicado en 2016

Complete remission of metastatic and relapsed uterine cervical cancers using weekly administration of bevacizumab and paclitaxel/carboplatin

artículo científico publicado en 2009

Complete remission of recurrent and refractory uterine epithelioid leimyosarcoma using weekly administration of bevacizumab and temozolomide ⬇️

artículo científico publicado el 26 de marzo de 2011

Complete remission of recurrent ovarian clear cell carcinoma by chemotherapy with bevacizumab, trabectedin and oxaliplatin ⬇️

artículo científico publicado el 20 de noviembre de 2012

Correlation of high LAT1 expression with the prognosis of endometrioid carcinoma of the uterine corpus

artículo científico publicado en 2020

Cumulative alterations of p27-related cell-cycle regulators in the development of endometriosis-associated ovarian clear cell adenocarcinoma

artículo científico publicado en 2010

DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers

artículo científico publicado en 2014

Different Prognostic Implications of Aquaporin-1 and Aquaporin-5 Expression among Different Histological Types of Ovarian Carcinoma

artículo científico publicado en 2018

Differential expression of FOXO1 and FOXO3a confers resistance to oxidative cell death upon endometrial decidualization

artículo científico publicado en 2006

Differential expression of hypoxia-inducible protein 2 among different histological types of epithelial ovarian cancer and in clear cell adenocarcinomas

artículo científico publicado en 2010

Effect of ARID1A/BAF250a expression on carcinogenesis and clinicopathological factors in pure-type clear cell adenocarcinoma of the ovary

artículo científico publicado en 2016

Effect of routine rapid insertion of Bakri balloon tamponade on reducing hemorrhage from placenta previa during and after cesarean section

artículo científico publicado en 2017

Effects of bevacizumab and pegylated liposomal doxorubicin for the patients with recurrent or refractory ovarian cancers ⬇️

artículo científico publicado el 23 de mayo de 2011

Efficacy and safety of triple therapy with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy for gynecological cancer: KCOG-G1003 phase II trial.

artículo científico publicado en 2014

Efficacy of combination chemotherapy using irinotecan and nedaplatin for patients with recurrent and refractory endometrial carcinomas: preliminary analysis and literature review.

artículo científico publicado en 2017

Evaluation of endometrial cytology: cytohistological correlations in 1,441 cancer patients

artículo científico publicado en 2014

Expression profiles of carcinosarcoma of the uterine corpus—are these similar to carcinoma or sarcoma? ⬇️

artículo científico publicado el 10 de noviembre de 2011

Factors favouring long-term survival following recurrence in ovarian cancer

artículo científico publicado en 2017

Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient

artículo científico publicado en 2011

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary

artículo científico publicado en 2014

High Expression of SQSTM1/p62 Protein Is Associated with Poor Prognosis in Epithelial Ovarian Cancer

artículo científico publicado en 2014

High Expression of p62 Protein Is Associated with Poor Prognosis and Aggressive Phenotypes in Endometrial Cancer

artículo científico publicado en 2015

High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.

artículo científico

Histological grading of ovarian clear cell adenocarcinoma: proposal for a simple and reproducible grouping system based on tumor growth architecture

artículo científico publicado en 2012

Identification of potential serum markers for endometrial cancer using protein expression profiling

artículo científico publicado en 2009

Impact of UGT1A1 genotype upon toxicities of combination with low-dose irinotecan plus platinum

artículo científico publicado en 2016

Indispensability of UGT1A1*6 genotyping in Japanese cancer patients treated with irinotecan

artículo científico publicado en 2010

Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas

artículo científico publicado en 2017

Is Modified Radical Hysterectomy Needed for Patients with Clinical Stage I/II Endometrial Cancers? A Historical Control Study

artículo científico publicado en 2016

Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy?

artículo científico publicado en 2017

JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.

artículo científico publicado en 2018

Less impact of adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study

artículo científico publicado el 1 de diciembre de 2010

Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations ⬇️

artículo científico publicado el 9 de diciembre de 2011

Low Expression of CD44 Is an Independent Factor of Poor Prognosis in Ovarian Mucinous Carcinoma

artículo científico publicado en 2018

Marginal sinus placenta previa is a different entity in placenta previa: A retrospective study using magnetic resonance imaging

artículo científico publicado en 2018

Massive intra-abdominal undifferentiated carcinoma derived from an endometrioid adenocarcinoma in a "normal-sized" ovary

artículo científico publicado en 2010

Multiple placental surface cysts with intracystic hemorrhaging: A case report and review of the literature

artículo científico publicado en 2017

Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection

artículo científico publicado en 2010

Outcomes of palliative bowel surgery for malignant bowel obstruction in patients with gynecological malignancy ⬇️

artículo científico publicado el 30 de julio de 2012

Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors

artículo científico publicado en 2020

Ovarian cancer therapeutic potential of glutamine depletion based on GS expression

artículo científico publicado en 2018

Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin

artículo científico publicado en 2017

PIK3CA mutation is an early event in the development of endometriosis‐associated ovarian clear cell adenocarcinoma ⬇️

artículo científico publicado el 7 de julio de 2011

PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma ⬇️

artículo científico publicado el 26 de noviembre de 2011

Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505.

artículo científico publicado en 2015

Phenoxodiol Increases Cisplatin Sensitivity in Ovarian Clear Cancer Cells Through XIAP Down-regulation and Autophagy Inhibition

artículo científico publicado en 2018

Placenta previa may acquire invasive nature by factors associated with epithelial-mesenchymal transition and matrix metalloproteinases

artículo científico publicado en 2020

Potential Survival Benefit of Secondary Cytoreductive Surgery for Recurrent Epithelial Ovarian, Tubal, and Peritoneal Cancers ⬇️

artículo científico publicado el 1 de febrero de 2011

Predicting time to ovarian carcinoma recurrence using protein markers.

artículo científico publicado en 2013

Predicting time to ovarian carcinoma recurrence using protein markers.

artículo científico publicado en 2013

Pregnancy with "mimicking placenta previa and large cervical leiomyoma" caused by incarcerated retroverted uterus.

artículo científico publicado en 2018

Pregnancy with asymptomatic uterine complete rupture after uterine artery embolization for postpartum hemorrhage

artículo científico publicado en 2017

Pretreatment Neutrophil-to-Lymphocyte Ratio Was a Predictor of Lymph Node Metastasis in Endometrial Cancer Patients

scientific article published on 20 March 2019

Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers

artículo científico publicado en 2017

Randomized phase II trial of paclitaxel plus carboplatin therapy versus irinotecan plus cisplatin therapy as first-line chemotherapy for clear cell adenocarcinoma of the ovary: a JGOG study

artículo científico publicado en 2010

Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m² versus 40 mg/m² in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial

artículo científico publicado en 2020

Rapid decrease in serum VEGF-A levels may be a worse prognostic biomarker for patients with platinum-resistant recurrent ovarian cancer treated with bevacizumab and gemcitabine

scientific article published on 11 April 2020

Relation between Birth Weight and Intraoperative Hemorrhage during Cesarean Section in Pregnancy with Placenta Previa

artículo científico publicado en 2016

Response to Correspondence "Asymptomatic uterine rupture detected at cesarean section: Some different viewpoints"

artículo científico publicado en 2017

Response to Correspondence: Marginal sinus placenta previa is a different entity in placenta previa: A retrospective study using magnetic resonance imaging

scientific article published on 01 December 2018

Response to correspondence "Prophylactic use of Bakri balloon for placenta previa surgery: A simple procedure to prevent balloon prolapse"

artículo científico publicado en 2019

Role and Regulation of the Serum- and Glucocorticoid-Regulated Kinase 1 in Fertile and Infertile Human Endometrium

article

Role of endometriosis as a prognostic factor for post-progression survival in ovarian clear cell carcinoma

artículo científico publicado en 2017

Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis.

artículo científico publicado en 2017

Short response duration even in responders to chemotherapy using conventional cytotoxic agents in recurrent or refractory clear cell carcinomas of the ovary ⬇️

artículo científico publicado el 3 de mayo de 2012

Significant relationship between the LAT1 expression pattern and chemoresistance in ovarian clear cell carcinoma

scientific article published on 13 January 2019

Silencing of the JNK pathway maintains progesterone receptor activity in decidualizing human endometrial stromal cells exposed to oxidative stress signals

artículo científico publicado en 2009

Simultaneous analysis of the gene expression profiles of cancer and stromal cells in endometrial cancer

scientific article published on 10 May 2014

Single nedaplatin treatment as salvage chemotherapy for platinum/taxane‐resistant/refractory epithelial ovarian, tubal and peritoneal cancers ⬇️

artículo científico publicado el 1 de agosto de 2010

Small Foci of Serous Component as a Predictor of Recurrence and Prognosis for Stage IA Endometrial Carcinomas

artículo científico publicado en 2017

Successful management of cervical pregnancy by selective uterine artery embolization: a case report

artículo científico publicado en 2004

The Haphazard Pattern in Grade-3 Endometrioid Carcinoma Is Associated with Poor Prognosis and Tumor Lymphocyte Infiltration

scientific article published on 27 February 2019

The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma: a multi-institutional retrospective study

artículo científico publicado en 2009

The impact of systematic lymphadenectomy for early-stage ovarian carcinomas

artículo científico publicado el 1 de noviembre de 2011

The mesenchymal transition subtype more responsive to dose dense taxane chemotherapy combined with carboplatin than to conventional taxane and carboplatin chemotherapy in high grade serous ovarian carcinoma: A survey of Japanese Gynecologic Oncology

artículo científico publicado en 2019

The use of magnetic resonance imaging to predict placenta previa with placenta accreta spectrum

artículo científico publicado en 2020

Thrombotic events induce the worse prognosis in ovarian carcinomas and frequently develop in ovarian clear cell carcinoma

scientific article published on 09 May 2019

Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells

artículo científico publicado en 2007

UGT1A1 polymorphisms in cancer: impact on irinotecan treatment

artículo científico publicado en 2017

Validation of the histologic grading for ovarian clear cell adenocarcinoma: a retrospective multi-institutional study by the Japan Clear Cell Carcinoma Study Group

artículo científico publicado en 2011

Weekly administration of bevacizumab, gemcitabine, and oxaliplatin in patients with recurrent and refractory ovarian cancer: a preliminary result of 19 cases

artículo científico publicado en 2013

Weekly administration of temsirolimus for heavily pretreated patients with clear cell carcinoma of the ovary: a report of six cases

artículo científico publicado en 2011

What is an appropriate second-line regimen for recurrent endometrial cancer? Ancillary analysis of the SGSG012/GOTIC004/Intergroup study.

artículo científico publicado en 2015

Zone Formation of Lymphocyte Infiltration at Invasive Front as a Biomarker of Prognosis in Endometrial Carcinomas

artículo científico publicado en 2018

Zone Formation of Lymphocyte Infiltration at the Invasive Front Results in the Prolonged Survival of Individuals With Endometrial Serous Carcinoma and Endometrioid Carcinoma With Serous Component

scientific article published on 01 April 2019

[Ⅱ.Recent Progress of Treatment Strategy for Recurrent Ovarian Cancers]

scientific article published on 01 February 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda